MBX Biosciences, Inc. (MBX)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $24k
- Aug 4 · No plan
- Form 4 sales
- 4
- On record
- Form 144 notices
- 17
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
- LockupAssumed dateDec 8, 2025 349 days ago
75 days from Sep 24, 2025. The prospectus also states 30 days.
Sales by reason
Timeline
- 1 Form 144 noticeNoticeMay 11, 2026 2026
Filed to sell 22,500 shares ($992k)
Bartram Richard, Former Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 144 noticeNoticeMay 13, 2026 +2 days
Filed to sell 15,000 shares ($554k)
Bartram Richard, Former Officer
No 10b5-1 planFirst sale on recordFiling
- 3 Form 144 noticeNoticeJun 9, 2026 +27 days
Filed to sell 10,833 shares ($321k)
Bartram Richard, Former Officer
No 10b5-1 planFirst sale on recordFiling
- 4 Form 144 noticeNoticeJun 10, 2026 +1 day
Filed to sell 9,167 shares ($280k)
Bartram Richard, Former Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 144 noticeNoticeAug 4, 2026 +55 days
Filed to sell 370 shares ($24k)
Azoulay Salomon, Officer
No 10b5-1 planFiling
- 6 Form 144 noticeNoticeAug 4, 2026 same day
Filed to sell 936 shares ($62k)
Hawryluk P. Kent, Officer, Director
No 10b5-1 planFiling
- 7 Form 4 saleNo planAug 4, 2026 same day
Sold 370 shares at $65.77 ($24k)
Azoulay Salomon, Chief Medical Officer
No 10b5-1 planSold 2.5% of holdings ($971k position)14,399 shares leftFollows a Form 144Filing
- 8 Form 144 noticeNoticeAug 17, 2026 +13 days
Filed to sell 3,745 shares ($256k)
Hawryluk P. Kent, Former Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales, notices and lockups (23)
Export watchlist as CSV| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 17, 2026 | Aug 17, 2026 | Hawryluk P. Kent | Former Officer | Form 144 notice | 3,745 | $256k | Notice | SEC | |
| Aug 4, 2026 | Aug 5, 2026 | Azoulay Salomon | Chief Medical Officer | Form 4 sale | 370 | $24k | 2.5% | No plan | SEC |
| Aug 4, 2026 | Aug 4, 2026 | Hawryluk P. Kent | Officer, Director | Form 144 notice | 936 | $62k | Notice | SEC | |
| Aug 4, 2026 | Aug 4, 2026 | Azoulay Salomon | Officer | Form 144 notice | 370 | $24k | Notice | SEC | |
| Jun 10, 2026 | Jun 10, 2026 | Bartram Richard | Former Officer | Form 144 notice | 9,167 | $280k | Notice | SEC | |
| Jun 9, 2026 | Jun 9, 2026 | Bartram Richard | Former Officer | Form 144 notice | 10,833 | $321k | Notice | SEC | |
| May 13, 2026 | May 13, 2026 | Bartram Richard | Former Officer | Form 144 notice | 15,000 | $554k | Notice | SEC | |
| May 11, 2026 | May 11, 2026 | Bartram Richard | Former Officer | Form 144 notice | 22,500 | $992k | Notice | SEC | |
| May 8, 2026 | May 11, 2026 | Azoulay Salomon | Chief Medical Officer | Form 4 sale | 70,003 | $2.7M | 82.6% | Routine | SEC |
| May 8, 2026 | May 8, 2026 | Azoulay Salomon | Officer | Form 144 notice | 70,003 | $2.7M | Notice | SEC | |
| May 8, 2026 | May 8, 2026 | Bartram Richard | Former Officer | Form 144 notice | 10,000 | $380k | Notice | SEC | |
| May 7, 2026 | May 7, 2026 | Bartram Richard | Former Officer | Form 144 notice | 10,000 | $322k | Notice | SEC | |
| May 6, 2026 | May 8, 2026 | Azoulay Salomon | Chief Medical Officer | Form 4 sale | 231 | $7k | 1.5% | No plan | SEC |
| May 6, 2026 | May 8, 2026 | Hawryluk P. Kent | President & CEO | Form 4 sale | 607 | $18k | 0.1% | No plan | SEC |
| May 6, 2026 | May 6, 2026 | Hawryluk P. Kent | Officer, Director | Form 144 notice | 607 | $18k | Notice | SEC | |
| May 6, 2026 | May 6, 2026 | Azoulay Salomon | Officer | Form 144 notice | 231 | $7k | Notice | SEC | |
| May 1, 2026 | May 1, 2026 | Bartram Richard | Former Officer | Form 144 notice | 5,000 | $159k | Notice | SEC | |
| Apr 22, 2026 | Apr 22, 2026 | Bartram Richard | Former Officer | Form 144 notice | 10,423 | $341k | Notice | SEC | |
| Mar 25, 2026 | Mar 25, 2026 | Bartram Richard | Former Officer | Form 144 notice | 1,061 | $30k | Notice | SEC | |
| Mar 16, 2026 | Mar 16, 2026 | Bartram Richard | Former Officer | Form 144 notice | 10,000 | $300k | Notice | SEC | |
| Jan 12, 2026 | Jan 12, 2026 | Cornelius James M | Former Director | Form 144 notice | 30,864 | $1.1M | Notice | SEC | |
| Dec 8, 2025 | Sep 25, 2025 | All locked holders | Lockup expiry | Lockup ends, assumed | SEC | ||||
| Oct 24, 2025 | Sep 25, 2025 | All locked holders | Lockup expiry | Lockup ends, assumed | SEC |